2014-04-29から1日間の記事一覧
Phase II study of vincristine sulfate liposome injection (Marqibo) and rituximab for patients with relapsed and refractory diffuse large B-Cell lymphoma or mantle cell lymphoma in need of palliative therapy.(Clin Lymphoma Myeloma Leuk 2014…
Long-term clinical and molecular remissions in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation.(Ann Hematol 2014;93:803-810)自家幹細胞移植を併用した大量化学療法(HDT-ASCT)の後に臨床的…
Phase I/II study of bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma, transformed, or mantle cell lymphoma.(Biol Blood Marrow Transplant 2014;20:536-542)標準的BEAMと自家造血…
Long-term follow-up of R-CHOP with bevacizumab as initial therapy for mantle cell lymphoma: clinical and correlative results.(Clin Lymphoma Myeloma Leuk 2014;14:107-113)[背景] 近年明らかになっている知見から、マントル細胞リンパ腫(MCL)では腫…
Phase 2 study of VcR-CVAD with maintenance rituximab for untreated mantle cell lymphoma: an Eastern Cooperative Oncology Group study (E1405).(Blood 2014;123:1665-1673)rituximab、bortezomib、modified hyper-CVADを組み合わせた寛解導入免疫化学…
Open-label, randomized, noninferiority study of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of advanced indolent NHL or MCL: the BRIGHT study.(Blood 2014;123:2944-2952)この多国間無作為化第3相臨床試験では、未治療の低悪性…
